Beta
ManageSearchChatDiscover
30471

Curcumin nanoemulsion a new formulation for an old drug: In vitro and in vivo study

Article

Last updated: 03 Jan 2025

OverviewSimilar Items

Subjects

-

Tags

Medicine

Abstract

Curcumin nano emulsion have been tested in vivo and in vitro for its antioxidant and antitumor activity, Cytotoxicity of curcumin nano emulsion have been studied in vitro and found that a concentration of 100 mg/ml decrease the EAC count by 29.4%. There was a very high significant increase in CAT activity by 135.2% and very high significant decrease in MDA level, ALT/GPT, AST/GOT and serum creatinine by 49.6%, 30.8%, 18.9% and 43.4% respectively.

DOI

10.21608/sjou.2017.30471

Keywords

antioxidant, antitumor, in MDA level, ALT/GPT, AST/GOT and serum creatinine

Authors

First Name

Helal

Last Name

I.

MiddleName

A.

Affiliation

Industrial Biotechnology Department- GEBRI institute- Sadat City University, Egypt

Email

helal_ali@gmail.com

City

-

Orcid

-

First Name

El Baz

Last Name

F.

MiddleName

A.

Affiliation

Industrial Biotechnology Department- GEBRI institute- Sadat City University, Egypt.

Email

-

City

-

Orcid

-

First Name

Maksoud

Last Name

I.

MiddleName

A.

Affiliation

Industrial Biotechnology Department- GEBRI institute- Sadat City University, Egypt.

Email

-

City

-

Orcid

-

Volume

4

Article Issue

1

Related Issue

5262

Issue Date

2017-07-01

Receive Date

2017-03-13

Publish Date

2017-07-01

Page Start

36

Page End

41

Print ISSN

2314-8640

Online ISSN

2356-8119

Article File

SJOU_Volume 4_Issue 1_Pages 36-41.pdf

PDF . 551.0kB

Link

https://sjou.journals.ekb.eg/article_30471.html

Detail API

https://sjou.journals.ekb.eg/service?article_code=30471

Order

5

Type

Original Article

Type Code

724

Publication Type

Journal

Publication Title

Scientific Journal of October 6 University

Publication Link

https://sjou.journals.ekb.eg/

MainTitle

Curcumin nanoemulsion a new formulation for an old drug: In vitro and in vivo study

Details

Type

Article

Created At

22 Jan 2023